Mustang Bio Inc (MBIO)
0.2186
0.00 (0.00%)
USD |
NASDAQ |
Oct 04, 16:00
0.2186
0.00 (0.00%)
After-Hours: 17:51
Mustang Bio SG&A Expense (TTM): 7.268M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 7.268M |
March 31, 2024 | 8.792M |
December 31, 2023 | 9.686M |
September 30, 2023 | 9.902M |
June 30, 2023 | 11.16M |
March 31, 2023 | 11.18M |
December 31, 2022 | 12.21M |
September 30, 2022 | 12.46M |
June 30, 2022 | 11.44M |
March 31, 2022 | 10.90M |
December 31, 2021 | 11.02M |
September 30, 2021 | 10.78M |
June 30, 2021 | 10.56M |
March 31, 2021 | 11.02M |
December 31, 2020 | 9.505M |
September 30, 2020 | 9.15M |
June 30, 2020 | 8.984M |
Date | Value |
---|---|
March 31, 2020 | 9.182M |
December 31, 2019 | 9.57M |
September 30, 2019 | 9.146M |
June 30, 2019 | 8.499M |
March 31, 2019 | 6.993M |
December 31, 2018 | 6.709M |
September 30, 2018 | 8.199M |
June 30, 2018 | 11.46M |
March 31, 2018 | 11.44M |
December 31, 2017 | 11.41M |
September 30, 2017 | 9.294M |
June 30, 2017 | 5.799M |
March 31, 2017 | 4.586M |
December 31, 2016 | 2.816M |
September 30, 2016 | 1.894M |
June 30, 2016 | 0.881M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
7.268M
Minimum
Jun 2024
12.46M
Maximum
Sep 2022
10.25M
Average
10.56M
Median
Jun 2021
SG&A Expense (TTM) Benchmarks
AIM ImmunoTech Inc | 22.70M |
Perspective Therapeutics Inc | 18.64M |
Protalix BioTherapeutics Inc | 14.41M |
Electromed Inc | 34.49M |
Armata Pharmaceuticals Inc | 13.38M |